MCL1 and Miyoshi myopathy: In this sense, a study with 60 MM patient samples demonstrated that 63% of them responded to the ex vivo inhibition of MCL‐1 [59] and MCL‐1 overexpression and dependence on this protein is a bad prognostic factor for MM patients [67].